Logo image of CPAY

CORPAY INC (CPAY) Stock Fundamental Analysis

NYSE:CPAY - US2199481068 - Common Stock

319.37 USD
+1.58 (+0.5%)
Last: 9/3/2025, 8:07:23 PM
319.37 USD
0 (0%)
After Hours: 9/3/2025, 8:07:23 PM
Fundamental Rating

6

Taking everything into account, CPAY scores 6 out of 10 in our fundamental rating. CPAY was compared to 102 industry peers in the Financial Services industry. While CPAY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CPAY is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make CPAY a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CPAY had positive earnings in the past year.
CPAY had a positive operating cash flow in the past year.
Each year in the past 5 years CPAY has been profitable.
CPAY had a positive operating cash flow in each of the past 5 years.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

CPAY has a Return On Assets of 5.14%. This is in the better half of the industry: CPAY outperforms 75.49% of its industry peers.
Looking at the Return On Equity, with a value of 26.72%, CPAY belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
The Return On Invested Capital of CPAY (10.80%) is better than 87.25% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CPAY is above the industry average of 7.59%.
Industry RankSector Rank
ROA 5.14%
ROE 26.72%
ROIC 10.8%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of CPAY (25.17%) is better than 78.43% of its industry peers.
CPAY's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 43.91%, CPAY belongs to the top of the industry, outperforming 84.31% of the companies in the same industry.
In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
CPAY's Gross Margin of 78.12% is amongst the best of the industry. CPAY outperforms 84.31% of its industry peers.
CPAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 43.91%
PM (TTM) 25.17%
GM 78.12%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

CPAY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CPAY has less shares outstanding
CPAY has less shares outstanding than it did 5 years ago.
CPAY has a worse debt/assets ratio than last year.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CPAY has an Altman-Z score of 2.05. This is not the best score and indicates that CPAY is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.05, CPAY is in the better half of the industry, outperforming 75.49% of the companies in the same industry.
CPAY has a debt to FCF ratio of 4.21. This is a neutral value as CPAY would need 4.21 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.21, CPAY is in the better half of the industry, outperforming 71.57% of the companies in the same industry.
CPAY has a Debt/Equity ratio of 1.91. This is a high value indicating a heavy dependency on external financing.
CPAY has a Debt to Equity ratio of 1.91. This is in the lower half of the industry: CPAY underperforms 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF 4.21
Altman-Z 2.05
ROIC/WACC1.35
WACC8%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.12 indicates that CPAY should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, CPAY is in line with its industry, outperforming 55.88% of the companies in the same industry.
CPAY has a Quick Ratio of 1.12. This is a normal value and indicates that CPAY is financially healthy and should not expect problems in meeting its short term obligations.
CPAY's Quick ratio of 1.12 is in line compared to the rest of the industry. CPAY outperforms 55.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.77% over the past year.
CPAY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.03% yearly.
The Revenue has grown by 9.22% in the past year. This is quite good.
Measured over the past years, CPAY shows a quite strong growth in Revenue. The Revenue has been growing by 8.45% on average per year.
EPS 1Y (TTM)13.77%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%12.75%
Revenue 1Y (TTM)9.22%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%12.95%

3.2 Future

The Earnings Per Share is expected to grow by 15.01% on average over the next years. This is quite good.
The Revenue is expected to grow by 10.09% on average over the next years. This is quite good.
EPS Next Y12.93%
EPS Next 2Y14.31%
EPS Next 3Y14.33%
EPS Next 5Y15.01%
Revenue Next Year11.3%
Revenue Next 2Y10.9%
Revenue Next 3Y10.62%
Revenue Next 5Y10.09%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

CPAY is valuated correctly with a Price/Earnings ratio of 15.97.
CPAY's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.84. CPAY is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 12.86, which indicates a correct valuation of CPAY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CPAY is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CPAY to the average of the S&P500 Index (22.48), we can say CPAY is valued slightly cheaper.
Industry RankSector Rank
PE 15.97
Fwd PE 12.86
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CPAY is valued a bit cheaper than 64.71% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CPAY is valued a bit cheaper than 73.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.69
EV/EBITDA 12.21
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

CPAY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CPAY may justify a higher PE ratio.
A more expensive valuation may be justified as CPAY's earnings are expected to grow with 14.33% in the coming years.
PEG (NY)1.23
PEG (5Y)1.59
EPS Next 2Y14.31%
EPS Next 3Y14.33%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (9/3/2025, 8:07:23 PM)

After market: 319.37 0 (0%)

319.37

+1.58 (+0.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners97.31%
Inst Owner Change-9.82%
Ins Owners3.52%
Ins Owner Change1.69%
Market Cap22.55B
Analysts81.82
Price Target393.28 (23.14%)
Short Float %2.37%
Short Ratio3.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.91%
Min EPS beat(2)-2.03%
Max EPS beat(2)-1.79%
EPS beat(4)0
Avg EPS beat(4)-1.76%
Min EPS beat(4)-2.03%
Max EPS beat(4)-1.45%
EPS beat(8)0
Avg EPS beat(8)-1.85%
EPS beat(12)2
Avg EPS beat(12)-1.27%
EPS beat(16)5
Avg EPS beat(16)-0.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.27%
Min Revenue beat(2)-2.93%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.43%
Min Revenue beat(4)-3.5%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.73%
Revenue beat(12)1
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.05%
PT rev (1m)-1.49%
PT rev (3m)-2.68%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-0.13%
EPS NY rev (1m)0.29%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)1.63%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 15.97
Fwd PE 12.86
P/S 5.41
P/FCF 11.69
P/OCF 10.66
P/B 5.74
P/tB N/A
EV/EBITDA 12.21
EPS(TTM)20
EY6.26%
EPS(NY)24.84
Fwd EY7.78%
FCF(TTM)27.31
FCFY8.55%
OCF(TTM)29.96
OCFY9.38%
SpS59.08
BVpS55.64
TBVpS-67.66
PEG (NY)1.23
PEG (5Y)1.59
Profitability
Industry RankSector Rank
ROA 5.14%
ROE 26.72%
ROCE 16.97%
ROIC 10.8%
ROICexc 13.11%
ROICexgc 87.43%
OM 43.91%
PM (TTM) 25.17%
GM 78.12%
FCFM 46.23%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
ROICexc(3y)14.83%
ROICexc(5y)13.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.71%
ROCE(5y)16.98%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y1.1%
ROICexc growth 5Y0.59%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
F-Score7
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF 4.21
Debt/EBITDA 3.42
Cap/Depr 51.24%
Cap/Sales 4.49%
Interest Coverage 3.69
Cash Conversion 96.28%
Profit Quality 183.69%
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 2.05
F-Score7
WACC8%
ROIC/WACC1.35
Cap/Depr(3y)47.52%
Cap/Depr(5y)42.51%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.03%
Profit Quality(3y)145.81%
Profit Quality(5y)152.95%
High Growth Momentum
Growth
EPS 1Y (TTM)13.77%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%12.75%
EPS Next Y12.93%
EPS Next 2Y14.31%
EPS Next 3Y14.33%
EPS Next 5Y15.01%
Revenue 1Y (TTM)9.22%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%12.95%
Revenue Next Year11.3%
Revenue Next 2Y10.9%
Revenue Next 3Y10.62%
Revenue Next 5Y10.09%
EBIT growth 1Y7.76%
EBIT growth 3Y12.22%
EBIT growth 5Y7.35%
EBIT Next Year33.23%
EBIT Next 3Y17.77%
EBIT Next 5Y15.62%
FCF growth 1Y40.15%
FCF growth 3Y17.6%
FCF growth 5Y10.19%
OCF growth 1Y37.41%
OCF growth 3Y17.47%
OCF growth 5Y10.8%